Latest news with #Goldstein
Business Insider
a day ago
- Business
- Business Insider
Flying taxi pilots could use AI for fast answers during emergencies, Archer CEO says
Archer Aviation is considering creating an AI flight manual for its air taxis, its CEO told Business Insider. "We look at using AI and LLMs [large language models] to help simplify things," Adam Goldstein said in an interview at the Paris Air Show this week. "So, we can look at anything from a flight manual — which may be quite complex, that you can query and ask questions — to internal tools to help us move faster. "You can imagine if you're in some type of scenario and there's a big flight manual, and you need to understand what to do very quickly, you don't want to be thumbing through some multi-hundred-page book," he added. "You want to ask a quick question, get your answer, and fix your problem." Pilots have manuals called quick-reference handbooks that outline procedures for emergencies or other situations where the aircraft signals a warning message. The handbooks are typically on a digital device that are easier to search. AI could make searching faster, but large-language models such as ChatGPT have faced criticism for sometimes generating incorrect information, known as hallucinations. Silicon Valley-based Archer has partnered with Palantir for work with AI, saying they would develop software to improve a range of systems, including air traffic control, movement control, and route planning. "There's big complicated systems that need near 100% reliability, if not 100% reliability, and that's why we partnered with Palantir," Goldstein told BI. He said he used ChatGPT daily: "I think it's a great way to do research and to view the world, and I only expect that to continue." Archer is one of the premier players in advanced air mobility, which is regarded as the next generation of aircraft. Its aircraft, Midnight, is electric and can take off and land vertically — called an eVTOL for short, or a "flying taxi." The goal is to transform commutes in cities. For example, Archer says it would take 9 minutes to travel between Newark Liberty International Airport and downtown Manhattan, instead of the roughly hourlong journeys by car or public transit. United Airlines has placed an order worth up to $1.5 billion, and Archer last month announced it was chosen as the official air taxi partner of the 2028 Los Angeles Olympics. Also in Paris on Tuesday, Transportation Secretary Sean Duffy announced an alliance to streamline the certification of eVTOLs, including the UK, Canada, Australia, and New Zealand. Archer plans to deploy its first Midnight aircraft in the United Arab Emirates later this year.
Yahoo
2 days ago
- Business
- Yahoo
Clear Choice Headsets & Technology Reinforces its Commitment to the Public Safety Market as a Sponsor and Exhibitor at NENA 2025
Showcasing New, Innovative Solutions for the Dispatch Community Wheeling, Illinois--(Newsfile Corp. - June 18, 2025) - Clear Choice Headsets & Technology, a premier provider of trusted headsets and communication solutions for the public safety market, is excited to announce it is a Bronze Level Sponsor and first time exhibitor (booth 1018) at the 2025 NENA (National Emergency Number Association) Conference & Expo at the Long Beach Convention Center, June 21-26. At the booth, attendees can see the latest communication offerings from top tier equipment suppliers, such as Secure Headset Group (SHG), Jabra, Yealink, EPOS and Shokz. "Our presence at NENA demonstrates our continued dedication and long term commitment to the public safety market," declared Peter Goldstein, CEO of Clear Choice Headsets & Technology. "While other companies are exiting this space, we have been ramping up our efforts by expanding our team, relocating to a larger facility, and collaborating with partners to develop high-performing equipment that meets the ever-evolving critical demands of the 911 community." As the exclusive distributor of Secure Headset Group® products, two recently introduced cables will be on display in the Clear Choice Headsets booth (1018). - SHG S D145-PTT/AMP Push-To-Talk CableA six-wire amplifier cable that provides PL QD (quick disconnect) to a PJ7 2-prong adaptor with an in-line PTT (push-to-talk) button, which has been tested over one million cycles. To view an enhanced version of this graphic, please visit: - SHG S D145-PTT Push-To-Talk CableA commercial grade 6-wire cable that provides PL QD (quick disconnect) to a PJ7 2-prong adaptor with a PTT button tested over one million cycles. To view an enhanced version of this graphic, please visit: In addition to these new products, attendees can see and try on a wide variety of headsets that relieve ear fatigue, ensure all day comfort, and are trusted already by dispatch centers across the country. Mr. Goldstein, along with SHG CEO, Aaron Gitler, and other team members, will be onsite at NENA to connect with customers, and discuss their current and future communication needs. "We offer a complete product portfolio, including custom headsets that are designed specifically for the public safety community," stated Mr. Goldstein, "For nearly four decades, dispatchers have been trusting our headsets during life's most critical moments. We plan to continue and grow this partnership for many more years to come. We look forward to meeting with attendees at NENA." About Clear Choice Headsets & Technology Clear Choice Headsets & Technology is a premier provider of a wide variety of headsets, conferencing solutions, and accessories. It is the one stop shop for the best communications equipment, representing many of the leading brands in the industry. In addition, it is the exclusive distributor of headsets and accessories from Secure Headset Group® (SHG), formerly known as Starkey Headsets. For almost four decades, Clear Choice Headsets has been providing best-in-class customer experience. Customers have a single point of contact, resulting in lasting and trusted partnerships. Clear Choice Headsets offers accurate and fast product fulfillment with a large product inventory in its centrally located Midwest warehouse. For more information, please visit or follow Clear Choice on LinkedIn and Facebook. For more information or to schedule a one-on-one meeting during NENA 2025, please contact: Lynn Ventimiglia-Lobitlynn@ 847-269-1422 © 2025 Clear Choice Headsets & Technology, LLC. All rights reserved. To view the source version of this press release, please visit Inicia sesión para acceder a tu cartera de valores
Yahoo
2 days ago
- Business
- Yahoo
A startup banks $66M to pursue ‘inclusive precision medicine'
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Actio Biosciences, a San Diego-based biotechnology startup, announced Wednesday it raised a $66 million Series B financing to support drug research it's initially aiming at rare genetic diseases, but sees having broader potential, too. Actio's most advanced program is in early-stage testing for the degenerative nerve disorder Charcot-Marie-Tooth disease, but may also be useful in treating overactive bladder, the company said. A second program focused on a genetic form of epilepsy is expected to enter the clinic by the end of the year. The startup's Series B round was co-led by new investor Regeneron Ventures and existing backer Deerfield Management. Canaan, Droia Ventures and Euclidean Capital also participated. Actio emerged from stealth in late 2023 with $55 million in Series A funding and, since then, has brought two small molecule drugs either into or near clinical testing. One of the medicines it's developing, ABS-1230, is for epilepsies caused by mutations in a gene called KCNT1. These KCNT1-related epilepsies can strike early and come with severe health complications, such as an impact on brain function or even death. They're also the target of programs Praxis Precision Medicines, Servier and Atalanta Therapeutics, among others, are pursuing through different drugmaking methods. David Goldstein, Actio's CEO and formerly co-founder of Praxis, claimed that small molecules still hold the most promise for targeting epilepsies related to KCNT1, mutations which cause the overactivation of a kind of ion channel expressed in the brain. Some researchers turned to biologics, believing that they may have a better chance dealing with the disease's myriad mutations, he said. However, Actio believes its drug ABS-1230, which blocks this malfunctioning ion channel, should inhibit all repeatedly observed, disease-causing mutations, making it useful to many patients with the condition. "This kind of inclusive precision medicine is a key priority for the company," Goldstein said. Actio's other drug, ABS-0871, blocks a different ion channel protein called TRPV4 and is currently in a Phase 1 trial with healthy volunteers. By the end of the year, though, Actio intends to start a Phase 1b study in people with the Type 2C form of Charcot-Marie-Tooth, which is characterized by severe muscle weakness and respiratory complications. ABS-0871 is hoping it will show promise in overactive bladder, too, as part of the company's strategy to use insights from its rare disease research in more common disorders. Actio began raising its Series B round at the beginning of the year, and was able to complete it despite an accelerating, sector-wide pullback that's making it harder for companies to close funding rounds. Goldstein attributed its success to picking programs that have 'very high biological plausibility.' 'I'm sure that the climate will return back to funding those ideas that might be huge payoffs later, but it's just a little bit hard to predict,' Goldstein said. 'You really need to have programs that have a pretty predictable path.' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business of Fashion
12-06-2025
- Business
- Business of Fashion
The Business of Beauty Global Forum 2025 Concludes with Farewell Celebration
NAPA VALLEY, California — After three days of transformative conversations and industry insights, the third edition of The Business of Beauty's Global Beauty Forum concluded with a farewell dinner. Hosted in partnership with L'Oréal Groupe, the evening celebrated The Business of Beauty Global Awards winners who were carefully selected by an esteemed jury including Imran Amed, BoF's founder and CEO, and Ali Goldstein, L'Oréal USA's president of mergers and acquisitions. Goldstein presented the Creative Execution Award in the Breakthrough Track to premium skincare label Akt London, founded by Ed Currie and Andy Coxon from the United Kingdom. The dinner served as both a celebration of these entrepreneurs' current achievements and a launch pad for the innovations that will chart beauty's next chapter, while providing an opportunity for guests to reflect together on learnings gleaned at the forum. Imran Amed, founder and CEO of The Business of Fashion, and Hailey Bieber, founder and creative director of Rhode. (Getty Images for The Business of Fashion) Those in attendance — from beauty industry leaders to retail executives and entrepreneurs — first gathered outside the Stanly Ranch Glasshouse, with its panoramic views overlooking the Napa Valley vineyards during golden hour. As guests took their seats for dinner, Amed and Goldstein delivered a toast reflecting on the remarkable achievements recognised by The Business of Beauty Global Awards. 'It has been so inspiring to hear our finalists' stories and learn about the challenges you have faced and the change you want to drive in the industry,' said Amed in his remarks. 'We are grateful to do these events alongside our partners, including L'Oréal, and over the past few days, we have worked together as part of the jury to deliberate on our winners.' Goldstein reinforced the collaborative spirit, adding: 'The spirit of L'Oréal is about identifying and supporting the beauty industry around the world, highlighting fantastic innovation, recognising great founders and great brands. This forum really brings that to light and we couldn't have been more excited to have been a part of it.' The award winners, selected from over 100 applicants from 17 countries and five continents, represented a diverse range of innovative companies and founders. The honorees were celebrated alongside an audience that included Hailey Bieber, Tracee Ellis Ross, Tarang Amin, Marc Terlet, Yasmin Sewell and Sydney Towle. Justine Skye, musical artist, and Joe Holder, founder of the Ocho System and wellness columnist at GQ. (Getty Images for The Business of Fashion) Hailey Bieber, founder and creative director of Rhode, and Tendai Moyo, co-founder and CEO of Ruka. (Getty Images for The Business of Fashion) From left to right: Robin Tsai, general partner at VMG Partners; Isamaya Ffrench, makeup artist and founder and creative director of Isamaya Beauty; Ali Goldstein, president of US mergers and acquisitions at L'Oréal Groupe; Priya Rao, executive editor at The Business of Fashion; Imran Amed, founder and CEO of The Business of Fashion; Marianna Hewitt, co-founder of Summer Fridays; and Carolyn Bojanowski, executive vice president of merchandising at Sephora. (Getty Images for The Business of Fashion) Melissa Butler, founder of The Lip Bar, and Christopher Skinner, chief revenue officer at Front Row. (Getty Images for The Business of Fashion) From left to right: Susan Yara, founder of Naturium; Charlotte Palermino, chief brand officer at Dieux; and Marianna Hewitt, co-founder of Summer Fridays. (Getty Images for The Business of Fashion ) Winners of The Business of Beauty Global Awards 2025, from left to right: Molly Sims, founder of YSE Beauty; Haisam Mohammed, founder of Unifrom; Kate Neal and Remi Paringaux, co-founders of Commune; Susanne Manasi, founder of Manasi 7; Tendai Moyo, co-founder and CEO of Ruka; and Andy Coxon and Ed Currie, co-founders of AKT London. (Getty Images for The Business of Fashion) Robin Tsai, general partner at VMG Partners, and Henry Davis, CEO of Sakara Life. (Getty Images for The Business of Fashion) Pilkyung Yoon Choi, CMO of Laneige, and Stella Kim, global director of merchandising at Sephora. (Getty Images for The Business of Fashion) This is a sponsored feature paid for by L'Oréal Groupe as part of a BoF partnership.
Yahoo
11-06-2025
- Health
- Yahoo
DPH chief: Mass. prepared to maintain vaccine access
BOSTON (SHNS) – The state public health chief called the firing of all 17 members of a federal vaccine advisory panel 'troubling' on Wednesday, while acknowledging that Massachusetts officials have been bracing for such a scenario. On Monday, U.S. Health and Human Services Secretary Robert Kennedy Jr. dismissed all members of the CDC's Advisory Committee for Immunization Practices, or ACIP. President Joe Biden's administration had appointed all 17 members, including 13 in 2024, and 'these appointments would have prevented the current administration from choosing a majority of the committee until 2028,' Kennedy's office said. 'In dismissing the members, the secretary stated his intention to repopulate the committee and to hold the scheduled ACIP meeting June 25 to June 27,' Public Health Commissioner Robbie Goldstein said. 'This news is troubling. It amends a science-based process that has informed vaccine recommendations and promoted vaccine access for decades. The future of federal vaccine policy is unclear.' In a statement Monday, Kennedy said the move was 'necessary to reestablish public confidence in vaccine science.' New members were not announced but Kennedy's office said they will 'ensure that government scientific activities are informed by the most credible, reliable, and impartial scientific evidence available.' At a virtual state Public Health Council meeting Wednesday, Goldstein said it's unclear if new ACIP members 'will continue to use evidence and science to guide our vaccine recommendations and vaccine policy.' 'We've been been preparing for a number of scenarios, including this one, and we are well positioned to respond and maintain access to vaccines across the state,' Goldstein said. 'Starting in November, we've been analyzing the legal and regulatory landscape, identifying resources that could be used to guide vaccine recommendations, strengthening our data systems to understand vaccine effectiveness, and building a coalition of like-minded, evidence-based public health organizations in this state and others.' The Massachusetts Vaccine Purchasing Advisory Council, which helps distributes vaccines recommended by the ACIP, is slated to meet Thursday in Waltham. At a public hearing on Friday, Massachusetts parents and medical providers urged state lawmakers to scrap religious exemptions for school immunization requirements. The plea came amidst measles outbreaks in the U.S. Meanwhile, vaccine opponents lamented potential state infringements on their faith and personal beliefs. Students from preschool to college are required to receive a bevy of vaccines, including for polio, Hepatitis B, and measles, mumps and rubella, according to the state Department of Public Health. State law allows students to seek medical and religious exemptions, and refiled bills from Rep. Andy Vargas and Sen. Edward Kennedy (H 2544 / S 1557) would eliminate the religious carveout for immunizations required in public, private and charter K-12 schools. Under the proposals, schools must submit data annually to DPH about how many students are vaccinated and how many received a medical exemption — with that information then made publicly available. 'Three of our Northeast neighbors — Connecticut, Maine and New York — have eliminated their non-medical vaccine exemptions in recent years,' Katie Blair, executive director of Massachusetts Families for Vaccines, told the Joint Committee on Public Health. 'They have seen subsequent improvements in immunization rates, increasing the herd immunity protection that their most medically vulnerable residents depend upon. It's time for Massachusetts to do the same.' The committee reported the legislation out favorably at the end of last session on Dec. 16. Democrats in the Health Care Financing Committee did not advance the proposal. The majority of vaccine exemptions are for religious reasons in Massachusetts, according to DPH. Some western and southeastern parts of the state, especially on the Cape and Islands, have higher rates of vaccine exemptions, and those areas 'may be more susceptible to disease outbreaks because these students are not fully protected,' DPH says. Kyle Abrahamson, a biomedical engineer, said he opposed the bills because they encroach on his 'free exercise of religion' and constitute 'tyrannical overreach' from state government. Abrahamson argued that removing the religious exemption would force him to choose between his faith and his child's education. He also spoke against Sen. Becca Rausch's so-called Community Immunity Act (S 1618) that would preserve religious vaccine exemptions but strengthen the exemption process and improve data reporting. 'Parents — not the state, nor any medical professional or anybody else — but parents are the paramount advocates for their own children,' Abrahamson said. 'If H 2554, S 1557 and S 1618 move forward, the state is taking away parents' faith and forcing parents to put their faith in them.' Julie Booras, co-founder of Health Rights Massachusetts, said she 'strongly' opposes all school-related vaccine bills before the committee. She testified in support of a Rep. John Gaskey bill (H 2431) that would block the state from requiring COVID-19 shots, mRNA vaccines or gene-altering procedures to enroll in K-12 schools, colleges or universities, as well as to enter private businesses or seek employment. 'This bill is critical to ensure the injustices of the COVID era can never happen again,' Booras said. 'Despite all of the information now available about the physical, emotional and financial harms caused by the COVID countermeasures, nothing has changed. No meaningful action has been taken to rein in the sweeping powers granted to the governor and public health agencies by the Massachusetts Legislature.' Vaccine supporters had emphasized new urgency over removing religious exemptions as they invoked the worsening measles outbreak in Texas and other hotspots. Texas has logged 744 measles cases since January, causing 96 people to be hospitalized and two deaths among school-aged children, according to the Texas Department of State Health Services. There were 1,168 confirmed measles cases and three confirmed deaths across the U.S. as of June 5, according to the latest data from the Centers for Disease Control and Prevention. Massachusetts has not recorded any cases. 'Measles is an awful disease with dangerous complications and side effects,' Dr. Richard Moriarty, a retired pediatric infectious disease specialist, said. 'With cuts in health care funding, how are we going to pay if there are outbreaks? Outbreaks are very expensive.' Moriarty did not specify the funding cuts, but the Trump administration has moved to slash billions of dollars in public health grants and congressional Republicans are advancing proposals to drastically cut Medicaid dollars to states. 'Measles is so infectious, we need 95% of a population immunized to prevent an outbreak,' Moriarty continued. 'We thought our schools were good in Massachusetts, but if you take a deep dive into them, 119 kindergartens have MMR rates less than 90%, 31 schools are below 80% in Massachusetts, 19% of our schools didn't even bother to report their immunization rates this year, and 24% report their rates only on rolling three-year averages.' Supporters emphasized that vaccine skepticism and misinformation is more common across the country, and the landscape is also marked by shifting federal vaccine recommendations and immunization schedules. 'My colleagues are spending so much time just re-educating parents who have trusted the medical system for years and now have been instilled with this fear, which is completely based on misinformation,' said Dr. Christina Hermos, division chief of infectious disease at UMass Memorial Children's Medical Center. 'The frontline pediatricians are burning out having these conversations. We're already having a crisis of people going into primary care across this nation.' Kennedy last month announced the CDC is no longer recommending COVID vaccines for healthy children and pregnant individuals. Goldstein on Wednesday said that COVID vaccines remain available. He stressed that vaccinating pregnant women can protect newborn babies who cannot get immunized yet. 'I want to be clear: We know that COVID vaccination prevents severe illness, hospitalization and death in those at risk, which includes children and pregnant people,' Goldstein said. 'DPH will continue to lift up the data and the evidence that are available to inform our recommendations. And we'll work with insurers, health care providers and others across the state to maintain access to evidence-based safe vaccines.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
